These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 22125944

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Muscarinic receptor antagonists for overactive bladder.
    Abrams P, Andersson KE.
    BJU Int; 2007 Nov; 100(5):987-1006. PubMed ID: 17922784
    [Abstract] [Full Text] [Related]

  • 3. Antimuscarinics and overactive bladder: other mechanism of action.
    Yamaguchi O.
    Neurourol Urodyn; 2010 Nov; 29(1):112-5. PubMed ID: 19693952
    [Abstract] [Full Text] [Related]

  • 4. Emerging drugs for treatment of urinary incontinence.
    Vij M, Robinson D, Cardozo L.
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):299-308. PubMed ID: 20384545
    [Abstract] [Full Text] [Related]

  • 5. The pharmacotherapy of overactive bladder.
    Athanasopoulos A.
    Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348
    [Abstract] [Full Text] [Related]

  • 6. Fesoterodine: a new agent for treating overactive bladder.
    Ellsworth P, Berriman SJ, Brodsky M.
    Am J Manag Care; 2009 Mar; 15(4 Suppl):S115-7. PubMed ID: 19355800
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG, Bachmann G, Scarpero H, Jumadilova Z, Sun F, Morrow JD, Guan Z, Bavendam T.
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Solifenacin succinate for the treatment of symptoms of overactive bladder.
    Maniscalco M, Singh-Franco D, Wolowich WR, Torres-Colón R.
    Clin Ther; 2006 Sep; 28(9):1247-72. PubMed ID: 17062299
    [Abstract] [Full Text] [Related]

  • 16. Mirabegron for overactive bladder syndrome.
    Drug Ther Bull; 2013 Aug; 51(8):90-2. PubMed ID: 23949821
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Review of cognitive impairment with antimuscarinic agents in elderly patients with overactive bladder.
    Wagg A, Verdejo C, Molander U.
    Int J Clin Pract; 2010 Aug; 64(9):1279-86. PubMed ID: 20529135
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.